Reinvested dividends from Kitron, DNB and Sparebanken Vest.
Targovax replaced with Episurf
Photocure seems to have found their way into Kaiser Permanente clinics, an important milestone.
Generally a pretty strong sentiment for Norwegian Biotech, with Ultimovacs following the lead of Vaccibody and also a optimistic spirit for Nordic Nanovector.
Great news from Targovax on their oncolytic virus ONCOS-102, so relocated my PCI Biotech position to Targovax for now.
Nordic Nanovector remains my single largest stock position! This is very nostalgic and I’m happy to see the company in such a bullish position.
The companys Q1 report with regards to patient recruitment was good, not quite great, so it was sold off a little bit by the market, but have found good footing above key support levels going into the summer.
Bitcoin remains in the 30.000 to 40.000 range, I have been carefully buying Spot Bitcoin, still not considering going back into the margin trading game.
Genmab has been performing fantastically, so shaving my position there just a bit to put some funds into Targovax.
Closely watching Photocure, looking to rebuy more if we don’t see any dumping action.
Quite bullish sentiment in Norwegian Biotech lately, including for PCI Biotech, so reinitiated a position in PCIB.
Eagerly awaiting Q1 report for Nordic Nanovector
Gold and Silver testing very critical resistance levels, and can be about to do a major move to the upside.
Bitcoin in turmoil after Elon Musk twitter meltdown. Extreme fear levels in the markets, but i feel comfortable with my current Bitcoin position. Buying a little bit of spot, but not using any margin accounts at all.
Ultimovacs providing 18mo update on their 2nd gen #telomerase#vaccine in combination with #Pembrolizumab in front line advanced malignant melanoma (N=20) 12mo data showed 12mo OS 85% and mPFS: not reached.
POC study done with ipi and nivo in same indication, 4 RCTs in total. https://t.co/tFkvzE9olj
— Fornybar / Biotekprofeten (@Biotekprofeten) May 18, 2021
Bitcoin has corrected sharply and then bounced, and i feel content with my current position after what I believe will be a last round of selling for the foreseeable future. A lot of positive buzz around Bitcoin in Norway this weekend after respected economist Kari Due Andresen tweeted she is no a Bitcoin Hodler A good time to try out my recommended services Blockfi and Mirai exchange?
Nordic Nanovector coming into Q1 presentation scheduled for may 26th on a high note after successfully raising funds that should see it well past important value inflection points. Management so far staying firm on guiding initial 100 day readout for PARADIGME within 2021, which would be a major breakthrough for the company. Interesting to see that Novartis got a late breaking abstract for their Lutetium 177 product at ASCO 2021
Genmab doing a very nice comeback.
Photocure has been performing fantastically, but I have chose to be a bit defensive on the position ahead of the next quarterly presentation, will look to rebuy a lot of stock in the not too distant future.
My Silver Bet is still on, after increasing position in physical silver during april, and also diversifying my finnish junior miner to american listed stocks Hecla Mining and Pan American Silver. Sotkamo Silver disappointed with its Q1 production numbers, and I may look at reallocating a little bit more. Get free silver by using my BullionVault affiliate Link
Kitron and Medistim positions going strong.
DNB is has put out a bid on competitor Sbanken, triggering a bit of controvercy. As a response to this, I have reallocated some DNB funds to my local contender Sparebanken Vest, who also owns Bulder Bank, who reports Sbanken customers are contacting them in droves about getting mortgage offers.
Will follow PCI Biotech after they finally reported first patient enrolled in the US in their Bile Duct Cancer clinicalt trial.
Pleased to see that my “Savings” lot is now above 30% weight in my portfolio. This is my bucket of funds that is not expected to move with the same kind of fluctuations as the rest of my portfolio, but should still not be considered as “low risk” investments by any means.
My cash position is too low mainly due to mye oversized silver bet, and i will be looking to adjust this this week. “Sell in may and stay away” still a rule to be respected.
Cut my Softox position at this point, will keep it at my watch list until further notice
May is Bladder Cancer Awareness Month. Our Photocure team participated in the @BladderCancerUS Virtual Walk to End Bladder Cancer to show our support. Check it out! Can you spot anyone you know? #BCANWalkpic.twitter.com/Pw4T2rtyaH
— Blue Light Cystoscopy with Cysview® (@Cysview) May 1, 2021
As expected, Nordic Nanovector used the bullish sentiment after its Q4 report to raise funds with a private offering, and a repair offering is now being tried in the market. I have increased my position, and will also buy the few shares I can get in the repair offering.
New CEO for the company looks to be very qualified with deep insight in novel drug works after his experience in Roche. Of course, Roche is one of the strongest contenders to be a future big pharma partner for NANOV, given the expected combination treatment potential in Betalutin + Rituximab. 🔗Blogpost about Nordic Nanovector
I am deep, deep, deep into the silver mines hoping that this huge bet will pay off handsomely towards the end of the year. A small setback in the private offering for Sotkamo Silver, but not expected based on the cash position of the company. 🔗Blogpost about Sotkamo Silver
Kitron submitted to the market a mouth wateringly bullish newsflow, and the market responded with rocketing the share price to All time High. To be honest, a good portfolio strategy would be to just go all in Kitron and then forget about the whole thing at this point. 🔗Blogpost about Kitron
Started a position in Nordic Mining which i intend to grow later in the year. Started off with a false beat as the company needed to raise funds for its own investment in Keliber Lithium mine in Finland. The ownership in Keliber ensures that Nordic Mining is not a one trick pony on Engebø Rutile.
My BEAR OBX position has not been working the intended way, and I will revert to holding good old cash NOK instead.
Bitcoin is almost back at ATH! My strategy of taking a good amount of profit enabled me to not spend much energy on the short term volatility at all. With bullish bitcoin newsflow lately it seems very likely that it will continue to follow the Plan B stock to flow trajectory!
Genmab has been pushed back along with rest of Big Biotech lately, but holding strong above 2000 DKK. Would not be surprised to see it double in value a few years down the road.
Photocure extremely strong! Pulling some chips off the table, but it looks set to become another strong norwegian medtech stock along with Medistim.
Softox with unexpected setback in announcing that the swedish regulatory authority has requested more information and this will cause delay to the hand desinfectant rollout in Europe. Exited the stock at 55 NOK, awaiting more news about progress for the company. Important to remember that the hand desinfectant really is a sideshow in the great scheme of things for Softx.
Steadily increasing the percentage of the porfolio in funds and other investments apart from single stock positions. Admittedly some of this is in physical silver where the same price volatility as in stocks can be expected.
Reallocated some from PCI Biotech to Ultimovacs to spread risk a little bit. Ultimovacs stock has corrected much more than I had expected given its pipeline newsflow. Also to be honest the leadership in Ultimovacs seem to be much more engaged with regards to shareholders lately. Of course, these stocks are extremely volatile, so always ready to make changes at short notice. 🔗 Blogpost about Ultimovacs
Current mood: Portfolio remains at ATH, not feeling any fomo at all. As mentioned in last update, february for me is a month of easing back on risk. Very much the same gut feeling as around january last year, its not going to take much to cause this market to have a solid selloff, be sure to have a good watch list of quality assets and funds ready to buy on sale.
After Bitcoin hit 46k, i have been offloading about 35% of my Bitcoin position. Some gains has been reinvested into stock portfolio, some being pulled out of portfolio and into familiy economy, and some remains on book as cash available. With Bitcoin at 58k (WOW!) it would be easy to consider this a loss, but I dont really spend much energy on such thinking.
As well as cash on the books, also retain a fairly large BEAR OBX x2 position, and a small BEAR US100 x2 position.
The first Bitcoin ETF was listed publicly in Canada! This is available for trading on my Nordnet Zero Account. Looks like a great option for going “more long” on Bitcoin without causing tax events.
The one asset I am super bullish on is Silver! A setback on my Sotkamo Mining position (october and november were less active mining months it was reported on Q4), but the rumour mill about serious supply problems in the market just keeps increasing. Increased my position in Sotkamo, and also looking for other silver plays this week. Daily Chart: Sotkamo Silver pullback after Q4 2020 presentation
Very happy to have see a fantastic Q4 report for Nordic Nanovector, started a new position there but being a bit carefull as the company is guiding it needs to raise cash before summer. The huge value kicker would be any kind of big pharma partnership, but base case is a 20% isusuance of new stock. Nordic Nanocector is admittedly much more than “just a stock” to me, it is both my true multibagger, but also I have Lymphoma patients in my familiy that are perfect candidates for Betalutin if they were to relapse. I want nothing more than for the company to succeed, and with new management it seems almost like a new entity. Daily Chart: Does PARADIGME protocol amendments mark the beginning of the end of Nordic Nanovector’s four year bear market? $NANOV
The highest volume of the day…at 6:57 pm ET…when New York is closed, Asia is yet to open and Europe is sleeping!! This is classic price manipulation from the Bullion Bank Cartel. Smash price for 83¢ in less than two minutes. The utterly worthless @CFTC yawns.#silversqueezepic.twitter.com/7xWxWFWs9O
All time high! With Tesla buying BTC and crypto prices mooning, my portfolio reached a very handsome new ATH, with the Bitcoin allocation finally reaching too scary levels. Time for a bit of rebalancing and securing some gains.
Today was the first time I sold Bitcoin since starting investing in the asset class last year. Using the great service from bitmynt.no as an offramp, I sold 25% of my Bitcoin at 46.700 price. Almost to the satoshi, this is the coins I bought between march 22nd and may 8th last year, at an average cost of 7500 USD at the time, making it my most profitable trade to date.
Increased silver holdings both with physical silver, and also a position in Sotkamo Silver.
Started a Bear Nasdaq 2X position to increase my index hedge.
Medistim clocking in a wonderfully drama free all time high!
Link Mobility has been performing very well, and could easily be set for another Jens Rugseth hype. Company is favourably priced compared to it swedish competitor Sinch.
Strongpoint was a stock that I had kind of just been observing for several years. It suddenly had a big breakthrough so I made sure to start a position. A classical case of my only problem being that i didn’t buy more.
To be able to afford the Strongpoint and Link Mobility positions, this meant scaling back exposure to high risk biotech, which feels ok at this time.
The Bacon Portfolio 